đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to compare the immune response, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00290303
Treatments Being Tested
Hepatitis D virus (HDV) is a major global health issue, with an estimated 1...
Status
Recruiting
Location
Aarhus University Hospital
Start Date
2026-04-23
Trial ID
NCT07610772
Treatments Being Tested
Immunoprophylaxis with two hepatitis B vaccinations following the hepatitis...
Status
Unknown
Location
Beijing Youan Hospital, Capital Medical University
Start Date
2018-06-10
Trial ID
NCT03476083
Treatments Being Tested
To evaluate whether hepatitis B immune globulin with a high level of antibo...
Status
Completed
Location
Multiple Locations
Start Date
1975-11
Trial ID
NCT00000580
Treatments Being Tested
Primary Objective: ⢠To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
Chronic hepatitis B (CHB) is a serious liver disease worldwideďźHBV MTCT is ...
Status
Unknown
Location
Beijing Ditan hospital,Capital Medical University
Start Date
2015-07
Trial ID
NCT02901418
Treatments Being Tested
Sanquin Plasma Products BV developed a new manufacturing process for the Qu...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2019-03-20
Trial ID
NCT03899142
Treatments Being Tested
Background: The ability of the immune system to function declines with agi...
Status
Unknown
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00863187
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781